- Home
- NUVB vs HBNC Comparison
NUVB vs HBNC Comparison
Compare NUVB & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- HBNC
- Stock Information
- Founded
- NUVB 2018
- HBNC 1873
- Country
- NUVB United States
- HBNC United States
- Employees
- NUVB N/A
- HBNC 862
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- HBNC Major Banks
- Sector
- NUVB Health Care
- HBNC Finance
- Exchange
- NUVB Nasdaq
- HBNC Nasdaq
- Market Cap
- NUVB 679.9M
- HBNC 662.8M
- IPO Year
- NUVB N/A
- HBNC N/A
- Fundamental
- Price
- NUVB $2.12
- HBNC $14.84
- Analyst Decision
- NUVB Strong Buy
- HBNC Hold
- Analyst Count
- NUVB 5
- HBNC 2
- Target Price
- NUVB $8.20
- HBNC $17.00
- AVG Volume (30 Days)
- NUVB 4.2M
- HBNC 134.0K
- Earning Date
- NUVB 05-07-2025
- HBNC 07-23-2025
- Dividend Yield
- NUVB N/A
- HBNC 4.30%
- EPS Growth
- NUVB N/A
- HBNC 88.54
- EPS
- NUVB N/A
- HBNC 1.02
- Revenue
- NUVB $10,957,000.00
- HBNC $201,164,000.00
- Revenue This Year
- NUVB $95.27
- HBNC $46.68
- Revenue Next Year
- NUVB $345.44
- HBNC $5.05
- P/E Ratio
- NUVB N/A
- HBNC $14.56
- Revenue Growth
- NUVB N/A
- HBNC 11.46
- 52 Week Low
- NUVB $1.54
- HBNC $11.46
- 52 Week High
- NUVB $3.97
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- NUVB 47.71
- HBNC 46.71
- Support Level
- NUVB $2.14
- HBNC $14.70
- Resistance Level
- NUVB $2.42
- HBNC $15.18
- Average True Range (ATR)
- NUVB 0.16
- HBNC 0.32
- MACD
- NUVB -0.01
- HBNC -0.10
- Stochastic Oscillator
- NUVB 27.71
- HBNC 24.00
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.